For our new video series, “What CEOs learn from board roles,” Heidrick & Struggles’ Tobias Petri speaks with Carsten Hellmann, the CEO of ALK-Abelló, a global pharmaceutical company specializing in immunotherapy, and non-executive director of Coloplast, a healthcare technology company. Hellmann talks about the ways his role as a non-executive director has benefitted his job as the CEO of ALK and what surprised him about joining the board of Coloplast. He also discusses the benefits and challenges of sitting on the board of an international company versus an exclusively Danish one in terms of both navigating regulation and building networks.

About the interviewer

Tobias Petri (tpetri@heidrick.com) is a partner in Heidrick & Struggles’ Copenhagen office and a member of the Healthcare & Life Sciences, Industrial, and CEO & Board practices.